CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
HAPLN4 | Hyaluronan and proteoglycan link protein 4 | Predicted secreted proteins
| | | | | Group enriched |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35G1 | Solute carrier family 35, member G1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A9 | Solute carrier family 5 (sodium/sugar cotransporter), member 9 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | Predicted intracellular proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | Predicted intracellular proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin type | Enzymes Predicted membrane proteins
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
NXPE2 | Neurexophilin and PC-esterase domain family, member 2 | Predicted intracellular proteins
| | | | | Group enriched |
SCT | Secretin | Predicted secreted proteins
| | | | | Group enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
AC004754.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000471331}; cDNA FLJ60496 {ECO:0000313|EMBL:BAG57772.1} | Predicted membrane proteins
| | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
C11orf86 | Chromosome 11 open reading frame 86 | Predicted intracellular proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
CEACAM20 | Carcinoembryonic antigen-related cell adhesion molecule 20 | Predicted membrane proteins
| | | | | Group enriched |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Group enriched |
FEV | FEV (ETS oncogene family) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
LYZ | Lysozyme | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
MUC13 | Mucin 13, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NOS2 | Nitric oxide synthase 2, inducible | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
OAT | Ornithine aminotransferase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SLC6A20 | Solute carrier family 6 (proline IMINO transporter), member 20 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |